Literature DB >> 12446731

Guanine nucleotide exchange factor, Tiam1, directly binds to c-Myc and interferes with c-Myc-mediated apoptosis in rat-1 fibroblasts.

Yoshiro Otsuki1, Masamitsu Tanaka, Takaharu Kamo, Chifumi Kitanaka, Yoshiyuki Kuchino, Haruhiko Sugimura.   

Abstract

The transcription factor c-Myc is important for the control of cell growth, cell cycle progression, neoplasia, and apoptotic cell death. Recently, c-Myc-binding proteins, which bind either to the N-terminal domain or the C-terminal domain of c-Myc, have been proposed as the key molecules to realize the mechanisms of these multiple c-Myc functions. We report in the present study on another protein, Tiam1, which is a specific guanine nucleotide exchange factor of Rac1 and which binds to c-Myc and modulates several of its biological functions. We were able to detect the direct binding and in vivo association between c-Myc and Tiam1. The necessary role in this interaction of the Myc box II of c-Myc was revealed in the cell extracts. The additional discovery of the intranuclear localization of Tiam1 in Rat1 cells and in neuronal cells of the mouse brain suggests this interaction may occur in the nucleus. Overexpression of Tiam1 repressed the luciferase activity of c-Myc and also inhibited the c-Myc apoptotic activity through this protein-protein interaction. Taken together, we concluded that Tiam1 is another c-Myc regulator, working in the nuclei to control c-Myc-related apoptosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12446731     DOI: 10.1074/jbc.M206733200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Tiam1 gene expression and its significance in colorectal carcinoma.

Authors:  Li Liu; De-Hua Wu; Yan-Qing Ding
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

2.  Regulatory roles for Tiam1, a guanine nucleotide exchange factor for Rac1, in glucose-stimulated insulin secretion in pancreatic beta-cells.

Authors:  Rajakrishnan Veluthakal; Suresh Vasu Madathilparambil; Phillip McDonald; Lawrence Karl Olson; Anjaneyulu Kowluru
Journal:  Biochem Pharmacol       Date:  2008-09-27       Impact factor: 5.858

3.  TIAM1 variants improve clinical outcome in neuroblastoma.

Authors:  Elena Sanmartín; Yania Yáñez; Victoria Fornés-Ferrer; José L Zugaza; Adela Cañete; Victoria Castel; Jaime Font de Mora
Journal:  Oncotarget       Date:  2017-07-11

4.  TIAM1-RAC1 promote small-cell lung cancer cell survival through antagonizing Nur77-induced BCL2 conformational change.

Authors:  Aishwarya Payapilly; Ryan Guilbert; Tine Descamps; Gavin White; Peter Magee; Cong Zhou; Alastair Kerr; Kathryn L Simpson; Fiona Blackhall; Caroline Dive; Angeliki Malliri
Journal:  Cell Rep       Date:  2021-11-09       Impact factor: 9.423

5.  β2-syntrophin and Par-3 promote an apicobasal Rac activity gradient at cell-cell junctions by differentially regulating Tiam1 activity.

Authors:  Natalie A Mack; Andrew P Porter; Helen J Whalley; Juliane P Schwarz; Richard C Jones; Azharuddin Sajid Syed Khaja; Anders Bjartell; Kurt I Anderson; Angeliki Malliri
Journal:  Nat Cell Biol       Date:  2012-10-28       Impact factor: 28.824

6.  Rac1 GTPase and the Rac1 exchange factor Tiam1 associate with Wnt-responsive promoters to enhance beta-catenin/TCF-dependent transcription in colorectal cancer cells.

Authors:  Pinella Buongiorno; Vaijayanti V Pethe; George S Charames; Susmita Esufali; Bharati Bapat
Journal:  Mol Cancer       Date:  2008-09-30       Impact factor: 27.401

7.  Mechanisms of primary and secondary estrogen target gene regulation in breast cancer cells.

Authors:  Véronique Bourdeau; Julie Deschênes; David Laperrière; Malika Aid; John H White; Sylvie Mader
Journal:  Nucleic Acids Res       Date:  2007-11-05       Impact factor: 16.971

8.  Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.

Authors:  Zhenling Li; Qixiang Liu; Junjie Piao; Fenjian Hua; Jing Wang; Guang Jin; Zhenhua Lin; Yan Zhang
Journal:  BMC Cancer       Date:  2016-08-25       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.